Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 ,inter alia, to consider and approve 1. To consider and approve Un-audited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genpharmasec Ltd has informed the BSE that its Board of Directors will meet on Thursday, 06 November 2025 at the registered office in Mumbai. The main agenda is to consider and approve the Un-audited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2025, along with the Limited Review Report from the auditors. As per insider trading rules, the trading window for directors, designated persons, and their relatives is already closed from 01 October 2025 and will reopen 48 hours after the results are declared. The intimation has been signed by Mr. Sohan Chaturvedi, Whole Time Director and CFO.
This is a routine regulatory intimation and does not have a direct impact on the stock price. Investors should watch for the actual Q2 FY26 results on 06 November 2025 for any meaningful business updates or financial performance signals.